Stephen A Hill - Net Worth and Insider Trading
Stephen A Hill Net Worth
The estimated net worth of Stephen A Hill is at least $16,026 dollars as of 2024-11-13. Stephen A Hill is the Director of Catalyst Biosciences Inc and owns about 1,381 shares of Catalyst Biosciences Inc (CBIO) stock worth over $10,592. Stephen A Hill is the Director of Cellectar Biosciences Inc and owns about 1,800 shares of Cellectar Biosciences Inc (CLRB) stock worth over $3,852. Stephen A Hill is also the Director of Lipocine Inc and owns about 309 shares of Lipocine Inc (LPCN) stock worth over $1,582. Details can be seen in Stephen A Hill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen A Hill has not made any transactions after 2020-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen A Hill
Stephen A Hill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen A Hill owns 4 companies in total, including Cellectar Biosciences Inc (CLRB) , Lipocine Inc (LPCN) , and Catalyst Biosciences Inc (CBIO) among others .
Click here to see the complete history of Stephen A Hill’s form 4 insider trades.
Insider Ownership Summary of Stephen A Hill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLRB | Cellectar Biosciences Inc | 2020-06-04 | director |
| LPCN | Lipocine Inc | 2017-12-29 | director |
| CBIO | Catalyst Biosciences Inc | 2015-12-17 | director & President & CEO |
 | | 2007-10-04 | director & President and CEO |
Stephen A Hill Latest Holdings Summary
Stephen A Hill currently owns a total of 3 stocks. Among these stocks, Stephen A Hill owns 1,381 shares of Catalyst Biosciences Inc (CBIO) as of December 17, 2015, with a value of $10,592 and a weighting of 66.09%. Stephen A Hill owns 1,800 shares of Cellectar Biosciences Inc (CLRB) as of June 4, 2020, with a value of $3,852 and a weighting of 24.04%. Stephen A Hill also owns 309 shares of Lipocine Inc (LPCN) as of December 29, 2017, with a value of $1,582 and a weighting of 9.87%.
Latest Holdings of Stephen A Hill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBIO | Catalyst Biosciences Inc | 2015-12-17 | 1,381 | 7.67 | 10,592 |
| CLRB | Cellectar Biosciences Inc | 2020-06-04 | 1,800 | 2.14 | 3,852 |
| LPCN | Lipocine Inc | 2017-12-29 | 309 | 5.12 | 1,582 |
Holding Weightings of Stephen A Hill
Stephen A Hill Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen A Hill has made a total of 0 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years. The most-recent trade in Catalyst Biosciences Inc is the acquisition of 333 shares on December 17, 2015, which cost Stephen A Hill around $10,150.
According to the SEC Form 4 filings, Stephen A Hill has made a total of 1 transactions in Cellectar Biosciences Inc (CLRB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cellectar Biosciences Inc is the acquisition of 1,800 shares on June 4, 2020, which cost Stephen A Hill around $19,440.
According to the SEC Form 4 filings, Stephen A Hill has made a total of 0 transactions in Lipocine Inc (LPCN) over the past 5 years. The most-recent trade in Lipocine Inc is the sale of 74 shares on December 29, 2017, which brought Stephen A Hill around $4,338.
Insider Trading History of Stephen A Hill
- 1
Stephen A Hill Trading Performance
GuruFocus tracks the stock performance after each of Stephen A Hill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen A Hill is 8.73%. GuruFocus also compares Stephen A Hill's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen A Hill within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen A Hill's insider trading performs compared to the benchmark.
Performance of Stephen A Hill
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.07 | | | | | |
| Relative Return to S&P 500(%) | 22.06 | | | | | |
Stephen A Hill Ownership Network
Ownership Network List of Stephen A Hill
Ownership Network Relation of Stephen A Hill
Stephen A Hill Owned Company Details
What does Cellectar Biosciences Inc do?
Who are the key executives at Cellectar Biosciences Inc?
Stephen A Hill is the director of Cellectar Biosciences Inc. Other key executives at Cellectar Biosciences Inc include Senior Vice President & Medical Andrei Shustov , Chief Commercial Officer Darrell Shane Lea , and Chief Financial Officer Chad J Kolean .
Cellectar Biosciences Inc (CLRB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cellectar Biosciences Inc (CLRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellectar Biosciences Inc (CLRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cellectar Biosciences Inc (CLRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cellectar Biosciences Inc Insider Transactions
Stephen A Hill Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen A Hill. You might contact Stephen A Hill via mailing address: 50 Avenue General De Gaulle, Bruxelles C9 9999999999.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
